Taiwan FDA registration 42a776077aea2401a2886c601dc495fc
Vitex immunoassay group Toxoplasma antibody IgM reagent
TW: 維特司免疫檢驗試劑組弓漿蟲抗體IgM試劑
Taiwan·Risk Class 2·ORTHO-CLINICAL DIAGNOSTICS·Registered Feb 09, 2009 – Feb 09, 2029ActiveRegistration details
- Analysis ID
- 42a776077aea2401a2886c601dc495fc
- Customs Code
- DHA00601994109
Company information
- Manufacturer
- ORTHO-CLINICAL DIAGNOSTICS
- Manufacturer Country
- United Kingdom
- Authorized Representative
- DKSH TAIWAN LTD.
Product details
- Intended Use
- For in vitro qualitative detection of Toxoplasma gondii antibody IgM in human serum and plasma (heparin, EDTA, or sodium citrate).
- Product Type (Level 1)
- A Clinical Chemistry and Clinical Toxicology;; C Immunology and Microbiology
- Product Type (Level 2)
- A.1150 校正品;; C.3780 弓漿蟲血清試劑
- Import Information
- import
Dates and status
- Registration Date
- Feb 09, 2009
- Expiry Date
- Feb 09, 2029
About this record
Access comprehensive regulatory information for Vitex immunoassay group Toxoplasma antibody IgM reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 42a776077aea2401a2886c601dc495fc and manufactured by ORTHO-CLINICAL DIAGNOSTICS. The authorized representative in Taiwan is DKSH TAIWAN LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices